@Ablate_Cancer Profile picture

$PVCT

@Ablate_Cancer

Immunotherapy PV-10 could potentially be well-positioned to pursue the lead indication of hepatic metastatic pancreatic cancer in a consequential clinical trial

Similar User
Bernard A Fox photo

@BernardAFox

Provectus Biopharmaceuticals, Inc. photo

@ProvectusBio

Oncology Forum UK photo

@OncologyForum

james robertson photo

@jamesrobertson7

Chape photo

@chape__

Pavel_Prosselkov photo

@PavelProsselkov

Kimberly George photo

@kimberlyanngeo

Weill Cornell Medicine Meyer Cancer Center photo

@WCM_MeyerCancer

Hygeia Health photo

@HygeiaH

OncoPolmoneIEO photo

@OncoPolmoneIEO

Diane Radford MD photo

@DianeRadfordMD

Oncopedia photo

@onco_pedia

Healthy Nutrition Ⓥ photo

@Saverforlater

Carla Rake photo

@carlarake1

Rozmanaria Limited photo

@Rozmanaria

*FDA Type C mtg 1H25 for clearance of the Company-sponsored #mPDAC P1 trial *data readout 4Q24 from NIH's National Eye Inst-funded REAGIR P3 trial of Bascom Palmer's Rose Bengal PDAT -pursue pre-IND submission mtg 1H25 -$3 million seed money, $20-$33 million valuation $PVCT


sec.gov/ix?doc=/Archiv… @funstocks1 Today’s conference call presentation slides appear to address your concerns I am looking forward to hearing more details from Mgt at 2pm eastern where they will be fielding questions $PVCT

@ProvectusBio very loyal and long term stake holders (all of us holding more than decade) are hoping for some thing substantial and at least clear path forward not same old BS. Clear catalysts, how they plan to monetize PV-10 and which data sets can validate PV-10 is what needed



I am hopeful Thursday’s CC finally brings meaningful news from Mgt and moves the needle… Q4 2024 Investor Update will be accessible by Zoom Webinar. Conference call will be held on Thurs, Nov 14, 2024 at 2 p.m. EST @funstocks1 $PVCT globenewswire.com/news-release/2…

Why every year we find new indication to chase instead of sticking to one specific indication ? Cutaneous melanoma, combo for melanoma, HCC, mCRC, mNET, mUveal and last 1-2 years it is mPDAC, wonder what will be in 2026 ? Also we need to stop blaming old mgmt after all these yrs.



-Subsequent to 09/30/2024 & in connection with the License Agreement with UM, Co entered into an agreement with non-related party investors for a seed round investment in NewCo, subject to negotiation, preparation & execution of definitive agreements, after NewCo is created $PVCT


$PVCT Reposted

$PVCT on Substack: Provectus Fourth Quarter 2024 Investor Update on November 14th at 2 pm ET Available by Zoom Webinar provectus.substack.com/p/provectus-fo… #RoseBengalSodium #RoseBengal #ConferenceCall

Tweet Image 1

Rose Bengal incorporated into nascent glioblastoma-derived M-NVs …showed an increased degree of internalization …and induced cytotoxic effects, even in an absence photodynamic direct stimulation …making a promising strategy for treating #glioblastoma scholar.google.com/scholar?hl=en&…


12/13/24 Rose Bengal PACK-CXL for infectious keratitis -Guillermo Amescua, USA [Bascom Palmer Eye Institute] 12/14/24 Long-Term Graft Survival after Rose Bengal Photodynamic Antimicrobial Therapy for Infectious Keratitis and Keratoplasty cxlexpertsmeeting.com $PVCT


Rose Bengal attenuates the Tau toxicity Rose Bengal was found effective against the various aspect of Tauopathy supporting it to be a neuroprotective molecule #alzheimers #dementia $PVCT researchgate.net/figure/Rose-Be…


Univ of Miami has entered into a licensing agreement with Provectus Bio, a company that specializes in pharmaceutical-grade Rose Bengal -partnership aimed at accelerating the commercialization of PDAT for the treatment of infectious #keratitis, benefiting patients worldwide $PVCT


Widespread use of fungicides has caused the fungi to gain resistance While ROS increased by 2-fold in conidia treated to PDI w BODIPY, it was decreased by 2-fold with Rose Bengal Findings -potential for PDI treatment with Rose Bengal as a new fungicide link.springer.com/article/10.100…


Antimicrobial resistance is an imperative health threat Antibacterial photodynamic therapy w Rose Bengal & small gluconamide-functionalized silica nanoparticles has emerged as a promising alternative strategy as it kills pathogens w/out inducing resistance preprints.org/manuscript/202…


A new Rose Bengal glycopolymer: Photosensitization in 2 stages -Antimicrobial photodynamic therapy is promising alternative vs antimicrobial resistance.We propose using polymers w Rose Bengal, mannosyl &pyridone as promising systems in photodynamic therapy sciencedirect.com/science/articl…


Conclusion: Rose Bengal mediated a-PDT as an adjunct to SRP was significantly more effective in improving GI, PPD and CAL and in reducing microbial count as compared with SRP alone in the management of chronic #periodontitis #RoseBengal #RoseBengalSodium liebertpub.com/doi/10.1089/ph…


$PVCT Reposted

$IQST $PVCT $RAFA looking ready...


$PVCT Reposted

CP's November 2024 issue is now live! In the latest issue: Examining artificial corneal endothelium, rose bengal photodynamic antimicrobial therapy for infectious keratitis+more! ow.ly/YQKl50TXSm1 Thank you to our Guest Editor Soosan Jacob, MS, FRCS, DNB @drsoosanjacob

Tweet Image 1

$PVCT Reposted

$PVCT with its RB-PDAT therapy for IF of the eye will be worth BILLIONS. Its a 10X bagger at its worst!


$PVCT Reposted

$PVCT Announces Investor Webinar for Fourth Quarter 2024 Conference Call globenewswire.com/news-release/2… #RoseBengalSodium #RoseBengal


Long-Term Graft Survival after Rose Bengal Photodynamic Antimicrobial Therapy for Infectious Keratitis & Keratoplasty …patients treated w OPK/DALK following Rose Bengal PDAT had better longterm probability of graft survival @1, 2 & 5 years post op $PVCT eyemicrobiology.upmc.com/2024%20Meeting…


Rose Bengal Photodynamic Therapy for Mycobacterium abscessus Keratitis: In Vitro Efficacy and Clinical Outcomes Rose Bengal PDAT is a feasible option to halt the progression of non-tuberculoid mycobacteria and could halt the need of enucleation. $PVCT eyemicrobiology.upmc.com/2024%20Meeting…


Loading...

Something went wrong.


Something went wrong.